Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer
2017 ◽
Vol 79
(3)
◽
pp. 497-505
◽
Keyword(s):
2014 ◽
Vol 74
(5)
◽
pp. 939-946
◽
Keyword(s):
Keyword(s):
2019 ◽
Vol 85
(10)
◽
pp. 2292-2301
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):